Photo: Depositphotos
Sep 23, 2025, 06:44
Therapeutic Plasma Exchange in Guillain-Barré Syndrome: ASFA 2023 Guidelines
Dr. Sumyea Kabir, Assistant Professor of Transfusion Medicine at BSMMU, shared a post on LinkedIn:
“Therapeutic Plasma Exchange (TPE) in Guillain-Barré Syndrome (GBS) – ASFA 2023 Snapshot
GBS is an Acute immune attack on peripheral nerves. ASFA 2023 places TPE as Category I, first-line therapy, equivalent to IVIG (but not combined).
Why it Works:
- TPE clears auto-antibodies and complement, helping nerves recover faster.
Protocol:
- ~1–1.5 plasma volumes per session
- 4–6 exchanges over 7–14 days
- Best started within the first week of symptoms.
Frontline Insight:
- I assisted in 7 GBS cases in My Residency Time at Bangladesh Medical University where, remarkably, after the first TPE session some patients regained limb movement and could sit upright. Early action truly saves function.
Monitor for Hypotension, Citrate-related Hypocalcemia, Bleeding risk, and central-line infection.
Reference: ASFA 9th Edition, 2023․”
Find more posts on Hemostasis Today.
-
Nov 14, 2025, 11:58Marilena Vrana: Can Public-only Blood Collection Systems Meet the Growing Patient Need for PDMs?
-
Nov 14, 2025, 11:48Cedric Hermans Shares the 1st Illustrated Review Dedicated to Hemophilia B
-
Nov 14, 2025, 10:28Valance Washington: Proud to Share Our Lab’s Latest Publication in Platelets Journal
-
Nov 14, 2025, 10:18Sripal Bangalore and Ajay Kirtane on TUXEDO-2 Comparison Focusing on Diabetic Patients
-
Nov 14, 2025, 10:11Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
-
Nov 14, 2025, 10:05Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
-
Nov 14, 2025, 09:58Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
-
Nov 14, 2025, 09:48Caitlin Raymond on ”The Plasma Chasers”
-
Nov 14, 2025, 09:42Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!